Evidence map›Paper›PMID 42400045›Full record

ArticleBMC psychology2026

The implementation of mindfulness-based cognitive therapy for patients with inflammatory bowel disease: a qualitative study.

Sabien J E Bosman, Myrthe van der Leegte, Milou M Ter Avest, Marloes J Huijbers, Loes H C Nissen, Wietske Kievit, Anne E M Speckens, Linda Kwakkenbos

Abstract read
In one paragraph

Article in BMC psychology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sabien J E BosmanDepartment of Psychiatry, Expertise Centre for Mindfulness, Radboud University Medical Centre, Nijmegen, Postbus 9101, 6500 HB, the Netherlands. sabien.bosman@radboudumc.nl.
Myrthe van der LeegteDepartment of Psychiatry, Expertise Centre for Mindfulness, Radboud University Medical Centre, Nijmegen, Postbus 9101, 6500 HB, the Netherlands.
Milou M Ter AvestDepartment of Psychiatry, Expertise Centre for Mindfulness, Radboud University Medical Centre, Nijmegen, Postbus 9101, 6500 HB, the Netherlands.
Marloes J HuijbersDepartment of Psychiatry, Expertise Centre for Mindfulness, Radboud University Medical Centre, Nijmegen, Postbus 9101, 6500 HB, the Netherlands.
Loes H C NissenDepartment of Gastroenterology and Hepatology, Jeroen Bosch Hospital, 's-Hertogenbosch, Netherlands.
Wietske KievitDepartment of IQ Health, Radboud University Medical Centre, Nijmegen, Netherlands.
Anne E M SpeckensDepartment of Psychiatry, Expertise Centre for Mindfulness, Radboud University Medical Centre, Nijmegen, Postbus 9101, 6500 HB, the Netherlands.
Linda KwakkenbosDepartment of Psychiatry, Expertise Centre for Mindfulness, Radboud University Medical Centre, Nijmegen, Postbus 9101, 6500 HB, the Netherlands.

Funding

ZonMw 555003201
6 · The paper itself

Abstract

backgroundOur recent trial studying mindfulness-based cognitive therapy (MBCT) for Inflammatory Bowel Disease (IBD) patients demonstrated reductions in psychological distress and improvements in well-being. Building on these findings, the present study aimed to explore barriers and facilitators for implementation and scenarios to overcome these.

methodsWe conducted a sequential two-part study consisting of qualitative interviews followed by a survey. Semi-structured interviews were conducted with key stakeholders (n = 32) on barriers and facilitators for implementation. The Consolidated Framework for Implementation Research guided data collection and framework analysis. Based on interview outcomes, implementation scenarios were formulated and presented in a survey to stakeholders (n = 21) to explore their perspectives on the most suitable scenario.

resultsKey barriers identified were scepticism and misconceptions about MBCT and its lack of evidence, and limited funding, time, and perceived competency to discuss mental health in medical consultations. Facilitators included the presence of a local champion, growing attention to lifestyle factors in society and healthcare, and the group-based design of MBCT providing peer support. Stakeholders preferred integrating MBCT within a regional network, but opinions differed. Irrespective of the preferred scenario, stakeholders emphasized the need for a strong business case, including evidence on long-term (cost-)effectiveness, to secure broad support and insurance coverage.

conclusionsAlthough implementing MBCT for IBD patients is worthwhile, several prominent barriers currently hinder this process. A strong business case is needed to gain broad support and insurance coverage. Further research is required to determine the most suitable and feasible implementation scenario and associated strategies. CLINICAL TRIAL NUMBER: not applicable.

Indexed as

Cognitive Behavioral TherapyInflammatory Bowel DiseasesMindfulnessAdultFemaleHumansMaleMiddle AgedQualitative Researchbarriersfacilitatorsimplementation, CFIRinflammatory bowel diseasemindfulness-based cognitive therapy

Identifiers

PMID42400045
PMCPMC13599151

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.